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SUMMARY
Propofol and isoflurane are commonly used in neuroanaesthesia. Some published data suggest that the use of these
agents is associated with impaired cerebral blood flow/carbon dioxide (CO2) reactivity. Cerebrovascular CO2
reactivity was therefore measured in three cohorts of adult merino sheep: awake (n=6), anaesthetized with steady-
state propofol (15 mg/min; n=6) and anaesthetized with 2% isoflurane (n=6). Changes in cerebral blood flow were
measured continuously from changes in velocities of blood in the sagittal sinus via a Doppler probe. Alterations in
the partial pressure of carbon dioxide in arterial blood (PaCO2) over the range 18-63 mmHg were achieved by altering
either the inspired CO2 concentration or the rate of mechanical ventilation. Cerebral blood flow/CO2 relationships
were determined by linear regression analysis, with changes in cerebral blood flow expressed as a percentage of the
value for a PaCO2 of 35 mmHg. Propofol decreased cerebral blood flow by 55% relative to pre-anaesthesia 
values (P=0.0001), while isoflurane did not significantly alter cerebral blood flow (88.45% of baseline, P=0.39).
Significant linear relationships between cerebral blood flow and CO2 tension were determined in all individual studies
(r2 ranged from 0.72 to 0.99). The slopes of the lines were highly variable between individuals for the awake cohort
(mean 4.73, 1.42-7.12, 95% CI). The slopes for the propofol (mean 2.67, 2.06-3.28, 95% CI) and isoflurane (mean
2.82, 2.19-3.45, 95% CI) cohorts were more predictable. However, there was no significant difference between these
anaesthetic agents with respect to the CO2 reactivity of cerebral blood flow.
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Under physiological conditions, cerebral blood
flow and arterial carbon dioxide tensions (PaCO2)
have a pseudo-linear relationship: hypercapnia
causes cerebral vasodilation, whilst hypocapnia
causes vasoconstriction. This mechanism is due to
CO2 induced changes in perivascular cerebral pH
resulting in changes in cerebrovascular tone1.
Cerebrovascular reactivity is also influenced by
cerebral tissue oxygenation2, calcium and potassium
fluxes and drugs such as volatile3,4 and intravenous
anaesthetics5,6. Although cerebrovascular carbon
dioxide reactivity is frequently used as a surrogate
index, several mechanisms determine metabolic
cerebral autoregulation.
Anaesthetic agents such as propofol and isoflurane
have effects on cerebral blood flow, cerebral blood
volume and intracranial pressure7. These factors 
may influence CO2 reactivity, thereby affecting
cerebral metabolic autoregulation (flow-metabolism
coupling). For example, during propofol anaesthesia,
cerebrovascular reactivity of blood flow and blood
volume is maintained during hypercapnia but is
markedly diminished during hypocapnia8. Precise
knowledge of the effects of anaesthetic agents on
cerebral blood flow/CO2 reactivity is clearly of clinical
importance, considering that these effects contribute
to the basis of their selection in neuroanaesthesia and
neuro-critical care. 
The evidence for these drug specific effects comes
from a number of physiological studies using a variety
of subjects and methods of measurement3,8-11. The
array of methods of measurement and study subjects
has resulted in conflicting opinion about the effects 
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of these anaesthetics on CO2 reactivity. This dis-
crepancy is highlighted further in studies using patho-
physiological models12-14. Few studies have directly
compared the effects of anaesthesia with the awake
state, using a consistent measurement of cerebral
blood flow.
The aim of this study was to determine the effect 
of propofol and isoflurane on cerebrovascular CO2
reactivity and to compare these with the awake state.
This study was conducted in a physiologically intact
ovine preparation using the same method for
measurement of cerebral blood flow in all cohorts.
METHOD
The Animal Ethics Committee of the University of
Adelaide approved the study. Animals were handled
in accordance with the Australian Code of Practice
for the Care and Use of Animals for Scientific
Purposes.
Studies were performed in three cohorts of adult
female merino sheep: awake or anaesthetized with
steady state propofol or isoflurane. The animals were
instrumented under thiopentone and halothane
anaesthesia as described previously15. In brief, a 2 cm
frontal craniotomy was performed anterior to the
trifurcation of the frontal and parietal sutures. A
bony plate was removed using a trephine and the
extradural portion of the sagittal sinus exposed. An
ultrasonic, range-gated Doppler transducer (Tritonics
Medical Instruments, Iowa) was placed on the dorsal
sagittal sinus. In the isoflurane and propofol cohorts,
a strain-gauge tipped intracranial pressure monitor
(Microsensor ICP Transducer, Codman, Randolph
MA, U.S.A.) was placed into the subdural space
through the same craniotomy. Both the Doppler
transducer and intracranial pressure monitor were
secured under the replaced bone flap which was fixed
with plate and bone screws.
The animal was turned supine and the femoral
triangle exposed. A 7 Fr catheter (Multipurpose A1
catheter, Cordis Corporation, Miami, U.S.A.) was
inserted into the femoral artery for measurement of
mean arterial pressure, intermittent sampling of
arterial blood gases and into the femoral vein 
for drug and fluid delivery. Through the femoral
venotomy, a thermodilution pulmonary artery
catheter (Model TD1755H, Biosensors International,
Singapore) was inserted and positioned into the pul-
monary artery under waveform imaging. A single
dose of penicillin/streptomycin was administered
peri-operatively for antibiotic prophylaxis. Sheep
were recovered from anaesthesia and returned to
housing crates where they were allowed free access to
food and water. Catheter patency was maintained
using intraluminal heparin (10 IU/ml) locks.
A period of two days elapsed between surgery and
measurements to allow a fibrous scar to develop
around the probe and the sagittal sinus. This ensured
minimal movement between the two and a constant
angle between the ultrasonic beam and the direction
of blood flow.
Awake studies
On the day of study, sheep were moved to a specific
study laboratory. The sheep were supported in a com-
fortable sling and extraneous noise was minimized to
reduce changes in cerebral blood flow induced by
startling. After a period to allow the animal to settle,
100% oxygen at 20 l/min was administered via a
sealed soft plastic mask attached to a semi-open
breathing circuit. Carbon dioxide was then intro-
duced into the circuit in increments, while oxygen
flow rates were reduced to maintain total flow at 
20 l/min. Following each increase in inspired carbon
dioxide concentration and when cerebral blood flow
had reached a new plateau, an arterial blood sample
was taken for gas analysis. The inspired concentration
of carbon dioxide was manipulated to keep arterial
carbon dioxide tension within the nominal range of
35-60 mmHg.
Anaesthetized studies
Prior to anaesthesia, the output of the Doppler
probes was recorded with the animal in an awake,
calm state. They were then induced with 200 mg
propofol and endotracheal intubation performed
(supine position). Thereafter, the studies were per-
formed in the sphinx position. For the isoflurane
cohort, maintenance of anaesthesia was with isoflu-
rane delivered via a vaporizer (Isotec 3, Ohmeda
BOC Group, U.K.) in the anaesthetic circuit to
maintain an end-tidal concentration of 2%. For the
propofol cohort, propofol was delivered via a syringe
driver (Model 33, Harvard Apparatus, MA, U.S.A.)
to maintain a constant infusion rate of 15 mg/min.
For both cohorts, the animals were mechanically
ventilated using a volume control ventilator (7000
Ventilator, Ohmeda, Madison, WI, U.S.A.) and
100% oxygen. Expired gas analysis of end-tidal CO2,
tidal volume and volatile agent (if appropriate) were
measured using an end-tidal analyser (Capnomac,
Datex Instrumentarium Corp, Helsinki, Finland).
After 1.5 hours to allow the induction agent to clear,
manipulations in CO2 were performed. Initial
measurements were made with the PaCO2 titrated to
35 mmHg. The allowed a direct comparison with the
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pre-anaesthesia cerebral blood flow value to deter-
mine the effect of each anaesthetic agent on cerebral
blood flow at normocarbia.
Subsequently, a range of PaCO2 levels were in-
duced by randomly increasing or decreasing minute
ventilation in a ramped manner by adjusting the tidal
volume and respiratory rates on the mechanical
ventilator. The minimum value of PaCO2 was that
achieved by maximal hyperventilation of the animal;
the maximum was that achieved by hypoventilating
the animal to the point where spontaneous respira-
tion occurred. Typically, six discrete levels of end-
tidal carbon dioxide were possible, with each charac-
terized by cerebral blood flow reaching a plateau
within approximately five minutes. At this point, an
arterial blood sample was taken for blood gas
analysis.
Mean arterial and intracranial pressures were
recorded throughout the studies using a standard
transducer and amplifier (78342A, Hewlett Packard
Company, CA, U.S.A.). Temperature was monitored
via the pulmonary artery catheter and maintained at
baseline levels via humidification of inspired gases
using a heat and moisture exchanger. Following the
studies, the sheep were recovered from anaesthesia
and transferred to their holding crates where they
were allowed free access to food and water.
Measurements
Changes in cerebral blood flow were inferred from
changes in the outputs from the Doppler probe. This
was sampled at 1Hz using an analog to digital card
(Metrabyte DAS 16-G2) and a personal computer
(Microbits 486-based IBM compatible) and recorded
digitally on computer disk. Mean arterial and
intracranial pressures were recorded through the
same computerised acquisition system. Both were
recorded as percentage changes from baseline values
and averaged over 30 seconds when end-tidal CO2
values stabilized at a discrete level.
Arterial blood gases for measurement of PaCO2
and pH where taken from the arterial catheter at 
the intervals outlined above and measured using a
standard blood gas analyser (ABL 625, Radiometer
Medical A/S, Copenhagen, Denmark).
Data analysis and statistics
Awake studies were performed on one occasion in
six different sheep (n=6). Anaesthetized studies were
performed on two occasions in three different sheep
(n=6). The significance level was 95% throughout.
Analysis of variance was used to test for differences
between individual sheep for these data.
The effect of anaesthesia on cerebral blood flow
(pre-anaesthesia vs 1.5 hours post anaesthesia) was
examined using a paired t-test. Relationships between
changes in cerebral blood flow and PaCO2 were
determined using linear regression analysis using a
spreadsheet program (Excel, Microsoft Corporation,
U.S.A.), with data normalized to the cerebral blood
flow at a PaCO2 of 35 mmHg. Thus, the vertical axis
of the regression lines represented the percentage
increase in cerebral blood flow from the baseline
value. Regression was performed on the individual
data from each animal. Linear regression was also
performed on the pooled data for the propofol and
isoflurane cohorts.
Pooled data were expressed as means and 95%
confidence intervals. Comparison between cohorts
was determined by the calculation of mean dif-
ferences and 95% confidence intervals assuming a 
t-distribution using the method described by
Motulsky16.
RESULTS
Propofol anaesthesia was characterized by a sub-
stantial, statistically significant decrease in cerebral
blood flow (55% of baseline, P=0.001) and a signifi-
cant increase in mean arterial pressure (132.4%
baseline, P=0.04). Isoflurane anaesthesia did not
significantly change cerebral blood flow (88.45% of
baseline, P=0.39) or mean arterial pressure (97.6%
of baseline, P=0.76) (Figure 1). 
Blood pressure, intracranial pressure and tempera-
ture did not significantly change from baseline
through the period of CO2 manipulation in all
cohorts (P>0.05). Significant correlations between
mean arterial pressure and PaCO2 (awake r2=0.46,
P<0.0001; isoflurane: r2=0.46, P<0.0001; propofol:
r2=0.43, P<0.0001); and intracranial pressure and
PaCO2 (isoflurane: r2=0.56, P<0.0001; propofol: 
r2= 0.51, P<0.0001) were demonstrated (Figure 2a
and 2b).
The range of PaCO2 achieved for the awake,
propofol and isoflurane cohorts were 31.7-63.2, 18.1-
50.6, and 20.6-52.3 mmHg, respectively. Significant
linear relationships between cerebral blood flow and
PaCO2 were found in all individuals (Figure 3a). For
the anaesthetized cohorts, the analysis of variance
showed no effect of sheep number on the slope of the
regressions (P=0.46 for propofol, 0.38 for isoflu-
rane), suggesting that intra-animal variability in the
data was comparable to inter-animal variability. 
In the awake cohort, regression lines demonstrated
increased cerebral blood flow for CO2 although
reactivity was highly variable between animals. In
415PROPOFOL, ISOFLURANE AND CO2 REACTIVITY
Anaesthesia and Intensive Care, Vol. 30, No. 4, August 2002
contrast, the reactivity under anaesthesia was more
consistent. The pooled data and their regression lines
are shown for propofol and isoflurane in Figure 3b.
By confidence interval analysis (Table 1), there was
no statistically significant difference between the
slopes of the regression lines between the awake and
anaesthetised cohorts (P=0.21 for awake vs propofol,
0.25 for awake vs isoflurane). There was no statistic-
ally significant difference between the slopes between
propofol and isoflurane anaesthesia (P=0.68).
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FIGURE 1: The effect of propofol (15 mg/min) and 2% isoflurane
anaesthesia on cerebral blood flow (CBF: closed circles) and mean
arterial pressure (MAP: open circles) expressed as % baseline
change compared to the baseline awake state (dashed line at
100%). Data are expressed as mean±SEM.
TABLE 1
Summary of the linear regression terms for individual cerebral blood
flow/carbon dioxide reactivity curves. Data are expressed as mean and
(lower to upper 95% confidence intervals)
r2 Slope Intercept
Awake 0.79 4.194 –44.68
(0.57 to1.00) (1.186 to 6.49) (–125.7 to 36.35)
Propofol 0.90 2.78 2.689
(0.85 to 0.96) (2.154 to 3.41) (–19.24 to 24.62)
Isoflurane 0.92 2.69 3.452
(0.87 to 0.97) (2.09 to 3.29) (–15.01 to 21.92)
FIGURE 2a: Relationship between mean arterial pressure (MAP:
expressed as % baseline change) and arterial carbon dioxide
tension (PaCO2: mmHg) in the awake (r2=0.46); isoflurane









































As expected, changes in PaCO2 were associated
with statistically significant inverse changes in pH: 
in the isoflurane cohort, the relationship had an
r2=0.95 (P<0.0001), propofol r2=0.86, (P<0.0001).
Statistically significant correlations were demon-
strated between changes in cerebral blood flow 
and pH in the isoflurane (r2=0.88, P<0.0001) and
propofol (r2=0.70, P<0.0001) cohorts, and are shown
in Figure 4.
DISCUSSION
The responsiveness of the cerebral vasculature to
changes in PaCO2 is an important mechanism for
metabolic autoregulation, cerebral volume regulation
and cerebral oxygen delivery. These homeostatic
mechanisms are influenced under anaesthesia, which
may be represented by the slope of the cerebral blood
flow/CO2 response curve. 
There have been many studies examining the re-
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FIGURE 2b: Relationship between intracranial pressure (ICP:
expressed as % baseline change) and arterial carbon dioxide
tension (PaCO2: mmHg) in the isoflurane (r2=0.56) and propofol
(r2=0.51) groups. There was no significant change from baseline




























FIGURE 3a: Regression lines of the percent change in cerebral
blood flow (CBF) versus arterial carbon dioxide tension (PaCO2:
mmHg) for each individual study in the awake, propofol and
isoflurane cohorts. The r2 values ranged from 0.72 to 0.99—only
the regression lines are shown for clarity.  Each line is a goodness-
of-fit for the data shown in Table 1. Cerebral blood flow is










































lationship between cerebral blood flow and PaCO2. 
A variety of methods of measurement of cerebral 
blood flow are used such as transcranial Doppler17,18
or microsphere8 studies. Many of these techniques
assume that cerebral blood flow is in a state of equi-
librium during such measurements. Despite these
disparities, the results and conclusions drawn from
such experiments have been remarkably consistent,
especially when one considers the variety of species
tested and the different experimental conditions
used. The (pseudo) linear relationship of cerebral
blood flow to PaCO2 over a range of approximately 30
to 70 mmHg is repeated in many standard texts of
physiology. 
The interplay with other factors such as mean
arterial pressure and the effects of anaesthetic agents
is less clear. Anaesthetic agents have variable 
effects on cerebral blood flow. Nitrous oxide causes
an absolute increase in cerebral blood flow, halo-
thane and isoflurane cause a relative increase by
uncoupling cerebral blood flow and metabolism,
whilst propofol, thiopentone and benzodiazepines
decrease cerebral blood flow7,10,19,20. However, as these
agents are frequently administered simultaneously in
clinical use, the effect of an individual agent on
cerebral blood flow and CO2 reactivity is difficult to
quantify.
There are numerous studies analysing CO2 re-
activity under anaesthesia to determine the degree of
alteration of cerebral metabolic autoregulation10,11,17,21.
Most of these studies have been conducted using a
number of anaesthetic techniques for a range of sur-
gical procedures, using varied techniques of cerebral
blood flow measurements. In studies using patients
undergoing cardiopulmonary bypass, factors such as
blood pressure and temperature may be potentially
confounding variables22. Many studies used end-tidal
CO2 measurement to estimate PaCO2, which may be
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FIGURE 3b: Regression curves for pooled data on cerebral blood
flow (CBF) and arterial carbon dioxide tension (PaCO2: mmHg)
for the propofol (r2=0.87, P<0.0001) and isoflurane (r2=0.91,
P<0.0001) cohorts. CBF is expressed as percentage change from



























FIGURE 4: Relationship between cerebral blood flow (CBF:
expressed as % baseline change) and arterial pH in the isoflurane
(r2=0.88, P<0.0001) and propofol (r2=0.70, P<0.0001) groups.
inaccurate in ventilated or hypotensive subjects. Not
surprisingly, there are conflicting data about the
degree and magnitude of cerebral CO2 responses
under anaesthesia. 
An important source of conflicting comparative
reports relates to the method of reporting changes in
cerebral blood flow in response to CO2. Absolute
changes in cerebral blood flow (usually expressed as
ml/100 g/minute/mmHg) may differ from relative
changes (expressed as % baseline change). This 
was highlighted in a study analysing carbon dioxide
reactivity during propofol-induced electroencephalo-
graphic suppression5, where absolute CO2 reactivity
was reduced whilst relative CO2 reactivity was main-
tained within normal limits within the same subject.
In this situation, cerebral blood flow and CO2 pre-
serve a normal relationship, albeit from a different
baseline level. In our study, we quantified the effect
of propofol and isoflurane on cerebral blood flow
compared to the awake state beforehand, and then
made our conclusions about the comparative effects
of anaesthesia in this context. 
To assess and compare the effects of individual
anaesthetic agent(s) on cerebrovascular CO2 re-
activity with awake conditions, it is important to use 
a validated measurement of cerebral blood flow in 
a homogeneous study population. The range-gated
Doppler ultrasound probe venous outflow method of
measuring cerebral blood flow in this study has been
validated in sheep as a measure of global cerebral
blood flow against angiographic, retrograde dye and
timed venous outflow studies. These validation
studies demonstrated that this method represents
75% total cerebral blood flow15. Furthermore, it has
been demonstrated to be in agreement with measure-
ments made using the Kety-Schmidt nitrous oxide
method in sheep23. Due to the anatomical structure of
the sagittal sinus in sheep, this vessel is not subject to
large variations in vessel diameter. Previous valida-
tion studies of this preparation have demonstrated
that vessel diameter did not change across a fourfold
change in flow, and the flow-velocity relationship
remained constant. The vessel diameter remained
constant and cerebral blood flow was laminar over
the range of flows studied, thereby maintaining the
correlation between flow and sinus blood velocities.
The data from this study demonstrate that under
awake conditions there was a linear relationship
between cerebral blood flow and PaCO2, but that the
slope of this relationship was highly variable between
animals. There is a neurogenic component to the
regulation of cerebral blood flow, which would be
more active in the awake state but not under anaes-
thesia, mediated partly by the sympathetic response
to hypercapnia. This was evident during the awake
studies when the sheep became visibly agitated as
PaCO2 increased. We speculated that this additional
component was the cause of the variability in the
awake studies. 
Hypercapnia was induced by different mechanisms
in the awake and anaesthetized cohorts—i.e., CO2
administration compared to alterations in mechanical
ventilation. It is unlikely that this had a significant
effect on CO2 reactivity as the ranges of CO2 pro-
duced were not significantly different between
cohorts and represented a physiological range. The
effects of mechanical ventilation on cerebral blood
flow were minimized by maintaining a euvolaemic
state and avoiding positive end-expiratory pressure.
The levels of alterations of cerebral blood flow under
anaesthesia were consistent with other published
studies that did not utilize mechanical ventilation7,20.
While the mean slopes of the reactivity curves did
not differ between awake conditions and anaesthesia,
this was a function of the high variability of the 
awake data, and the trend in the data suggests that
reactivity under awake conditions is generally higher
(i.e. higher slope) than under anaesthesia. What is
clear, however, is that the slopes of the lines for
isoflurane and propofol were determined with high
precision, and that there was no statistically signifi-
cant difference between the CO2 reactivity curves for
these anaesthetic agents. This suggests that anaes-
thesia per se, irrespective of the agent used, is the
main determinant of alteration of CO2 reactivity.
Isoflurane and propofol were chosen because 
of their predominance in neuroanaesthesia. Volatile
agents such as isoflurane abolish cerebral autoregula-
tion in a concentration dependent manner. Two per
cent isoflurane concentrations were selected in
accordance with previous studies demonstrating
adequacy of anaesthesia and stability of cerebro-
vascular volumes over a range of PaCO221. Propofol
infusion rates were selected following previously pub-
lished studies from our laboratory analysing the cere-
bral pharmacokinetics of propofol in sheep24-26. No
significant changes in mean arterial pressure,
intracranial pressure or temperature was observed
during these studies during the hypercapnic or
hypocapnic ranges. Given the stability of the model,
accuracy of cerebral blood flow and PaCO2 measure-
ment, and steady-state conditions of anaesthesia, the
observed effect of these agents on CO2 reactivity are
attributable to the agent alone.
The linearity of the reactivity curve was maintained
over the range of PaCO2 studied, making this study at
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variance to others that have suggested that cerebral
blood flow responses to CO2 plateau outside of the
range 25 to 70 mmHg27. However, as the range of
PaCO2 produced represented a physiological range
(18-63 mmHg), we cannot draw any conclusions
about the shape of the reactivity curve at CO2 ranges
above or below this range. Flattening of cerebral
blood flow is expected at PaCO2 levels <20 mmHg:
cerebral blood flow responses below this threshold
will need to studied specifically to exclude a species-
specific phenomenon. The mechanism for this
phenomenon remains unclear, but has been
attributed to pH-mediated changes in cerebro-
vascular responsiveness. The strong association
between cerebral blood flow and pH demonstrated 
in Figure 4 is supportive of this hypothesis. Other
mechanisms suggested include coupled changes cere-
bral blood flow and metabolism and alterations in
cerebral blood volumes.
This study used a global measurement of cerebral
blood flow in a physiologically intact preparation. 
It therefore does not provide information about
regional changes in cerebral blood flow which may be
significant, particularly in situations where cerebral
autoregulation is impaired by pathological processes.
Similarly, the cumulative effects of anaesthetic agents
in patients may have significant effects of cerebral
autoregulation. Cerebral autoregulation is a complex
process involving myogenic and metabolic systems,
and varies under pathophysiological conditions18. Any
deduction about the effect of one aspect of this
process on overall autoregulatory function must be
made with circumspection.
In conclusion, cerebral blood flow was shown to
always increase in a linear manner with increases 
in PaCO2. Isoflurane and propofol anaesthesia pro-
duced more predictable CO2 reactivity curves than
for the awake state, which tended to produce steeper
reactivity curves (possibly due to an additional
reactive autonomic component to cerebral blood
flow). However, there was no significant difference
between these anaesthetic agents with respect to the
CO2 reactivity of cerebral blood flow.
This study was funded by the National Health 
and Medical Research Council of Australia, Grant
157952.
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